ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668300; 2) Community: the network communities that were significantly associated with the response to NSC 668300; 3) Molecule: the relationships between components within communities and NSC 668300; 4) MDR: the compounds that were significantly associated with the NSC 668300.

NSC Compound Enrichment Correlation
NSC 674178 Null 0.00166185890990729 0.33048498
NSC 674278 Null 0.00166185890990729 -0.34224327
NSC 720340 Null 0.00166185890990729 0.32740728
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.00166185890990729 0.24927487
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00166185890990729 0.21596911
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.00166561193816139 0.15496022
NSC 641297 ANTINEOPLASTIC-641297 0.00166561193816139 0.6991655
NSC 653624 Null 0.00166561193816139 0.34697868
NSC 675988 11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- 0.0016656119381614 0.45669376
NSC 689533 Hydrazinecarbothioamide, 2-[(2-pyridinyl)phenylmethylene]- N,N-bis[(2-pyridinyl)methyl]- 0.0016656119381614 0.5518837
Total:105  Current:6    [First] [Prev] [Next] [Last]